 |
|
Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
Keun-Sik Hong, Oh Young Bang, Jong-Ho Park, Jin-Man Jung, Sang-Hun Lee, Tae-Jin Song, Hyo Suk Nam, Hee-Kwon Park, Keun-Hwa Jung, Sung Hyuk Heo, Jaseong Koo, Kyung-Ho Yu, Kwang-Yeol Park, Chi Kyung Kim, Hong-Kyun Park, Jiyoon Lee, Juneyoung Lee, Woo-Keun Seo
J Stroke. 2023;25(2):242-250. Published online 2023 Apr 11 DOI: https://doi.org/10.5853/jos.2022.02957
|
|
Citations to this article as recorded by
 Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy
Sha Li, Hui-Hui Liu, Jian-Jun Li
Drugs.2025; 85(1): 51. CrossRef Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials
Abdelrahman Mahmoud, Hazem Mohamed Salamah, Hazem Rezq, Yazan Al-Mohtasib, Ali Ashraf Salah Ahmed, Mohamed R. Abdelraouf, Ahmed Mazen Amin, Ahmed A. Ibrahim, Yasmine Adel Mohammed, Omar Ahmed Abdelwahab, Majd M. AlBarakat, Salem Elshenawy, Husam Abu Suili
Baylor University Medical Center Proceedings.2025; : 1. CrossRef Are We Using Ezetimibe As Much As We Should?
Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, Antonis S Manolis
Biomarker Insights.2024;[Epub] CrossRef Achievement of LDL‐Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA‐AP Study
Sergio Cinza-Sanjurjo, Vivencio Barrios, David Fierro-González, Jose Polo-García, Vicente Pallarés-Carratalá, Arquimedes Gasparotto Junior
Cardiovascular Therapeutics.2024;[Epub] CrossRef In patients with atherosclerotic cardiovascular disease, is moderately intensive statin plus ezetimibe as effective as high dosed statin therapy?
Megan Doyle, Deborah Midgley, Joanna Wu
Evidence-Based Practice.2024; 27(11): 16. CrossRef The effectiveness of a multi‑target therapy polypill in patients with hypertension and dyslipidemia after novel coronavirus infection
V. E. Oleinikov, I. V. Avdeeva, K. I. Pavlenko, I. A. Babkina, Yu. A. Tomashevskaya
"Arterial’naya Gipertenziya" ("Arterial Hypertension").2024; 30(3): 326. CrossRef Safety and efficacy of moderate-intensity statin plus ezetimibe versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease: A meta-analysis
Francinny Alves Kelly, Francisco Cezar Aquino de Moraes, Artur de Oliveira Macena Lôbo, Victória Morbach Siebel, Marianna Leite, Artur Menegaz de Almeida, Fernanda Marciano Consolim-Colombo
Journal of Clinical Lipidology.2024; 18(6): e893. CrossRef
|